ROCKVILLE, Md.--(BUSINESS WIRE)--Global Research Services, LLC (GRS), an international clinical research organization (CRO) specializing in cardiovascular and metabolic pharmaceuticals, biotechnologies and medical devices, announced today the unveiling of a new strategic service to be managed by biopharmaceutical commercialization expert and experienced therapeutic product developer, Peter Milner, M.D. This specialized program aligns clients with key potential investors and integrates service needs with providers for acceleration of clinical development programs.
